About Delphia Therapeutics
Delphia is pioneering activation lethality - a next-generation precision medicine approach that targets cancer's surprising vulnerability to oncogene overactivation.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United States
Year Founded
2022
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
delphiatx.com
Domain Registered Date
Oct 6, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $67,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
delphiatx.com
- Milestone
Company founded
Cambridge, United States
Investors & Backers
Alexandria Venture Investments
GV
Nextech Invest
Polaris
Funding History
Series-A
· May 2, 2024
$67,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026